WASHINGTON - SEPTEMBER 29: (L-R) Office of Compliance of the Food and Drug Administration's Center for Drug Evaluation and Research Division Director Michael Levy, Drug Enforcement Administration Deputy Assistant Administrator Joseph Rannazzisi, United States Anti Doping Agency CEO Travis Tygart, Interim Executive Director and CEO for the scientific & regulatory affairs of the National Nutritional Foods Association Daniel Fabricant and Richard Kingham, partner at Covington & Burling LLP, are sworn in before testifying to the Senate Judiciary Committee's Crime and Drugs Subcommittee during a hearing on 'Body Building Products and Hidden Steroids: Enforcement Barriers' on Capitol Hill September 29, 2009 in Washington, DC. The committee is considering drawing up legislation that would give the Food and Drug Administration the responsibility of screening dietary suppliments for illegal steroids before they can be marketed and sold.